Skip to main content
. 2020 Oct 8;64(5):636. doi: 10.20945/2359-3997000000305

Table 2. Clinical conditions and groups that benefit from 25-hydroxyvitamin (25[OH]D) concentrations above 30 ng/mL.

Groups Clinical Conditions
Elderly (> 65 years) Osteoporosis (primary or secondary)
Pregnant women Fractures due to fragility
Metabolic bone diseases (osteomalacia, osteogenesis imperfecta, primary hyperparathyroidism)
Secondary hyperparathyroidism
Sarcopenia
Recurring falls
Chronic renal disease
Malabsorption syndrome
Liver failure
Diabetes mellitus type 1
Cancer